ArticlePloS one2023

Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.

Léna Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.